CARRE Foundation Benefactors Step Up at Outlook Leadership Conference
Industry community supporting, funding Multiple System Atrophy research
Published in CSP Daily News
SCOTTSDALE, Ariz. -- CSP's Charitable Alliance of Restaurant & Retail Executives (CARRE) Foundation is pleased to announce that more than $240,000 in funding has been raised with the generous support of Outlook Leadership's convenience retailing community to support Multiple System Atrophy (MSA) research.
MSA is a rare and fatal neurodegenerative disease with no identified cause, treatments or cure. CARRE has partnered with the MSA Coalition, Translation Genomics Research Institute (TGen) and the Outlook Leadership community to raise funding and awareness to find a cure for MSA.
Hess Corp., Huck's, Nestle Waters North America and Tedeschi Food Shops led and bolstered the fundraising efforts throughout the Outlook Leadership conference for CARRE and The Quest to Cure MSA in Honor of Rex Griswold and Tom Gillard (or Quest to Cure MSA).
A new sense of hope for humanity was felt by all who attended Outlook Leadership this year. "Advocacy plays an increasingly important role in raising awareness, and much needed funding, in today's research environment. The commitment of CSP through its Outlook Leadership conference and CARRE's on-site efforts are a perfect example of how science can partner with industry to make a substantial difference, and accelerate progress, against a rare disease like multiple system atrophy," said Dr. Jeffrey Trent, president and research director of the Translational Genomics Research Institute.
Honorary Outlook Leadership guest, Tom Gillard, formerly of Tropicana, QTG and MET-Rx, said, "Outlook was an outstanding effort to raise awareness of MSA. Through its fundraising, a great deal of research will hopefully aid in unlocking the answer to MSA."
Rex Griswold, Nestle Waters North America's vice president of sales, and his family, also joined the Outlook Leadership community to take part in supporting the initiation of this historic research. After Outlook, Rex stated, "New hope to finding a cure for MSA has been realized from the CARRE Foundation through funds raised at the Outlook conference. Besides groundbreaking research by TGen, the MSA Coalition is going to be able to fund research that is high on their priority list!"
"The Multiple System Atrophy Coalition could not be more pleased with the level of awareness and the donations generated by the CARRE Foundation during the annual CSP Outlook Leadership conference" stated Judy Biedenharn, president of The MSA Coalition. "The conference presentations regarding MSA were outstanding. You could see how moved attendees were by the courage being demonstrated by their two colleagues who are fighting this rare disease. There weren't many dry eyes in the room after the session on MSA. Later this year the MSA Coalition will be reviewing MSA research grant proposals and awarding research grants to help find a cause and a cure. The money raised by CARRE will allow us to fund significantly more research and gives us better hope of achieving a breakthrough in the near future. We are truly thankful to the CARRE Foundation for their dedication to our cause."